Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefu Zhuyu Capsule combined with clopidogrel after PCI in coronary heart disease
ChiCTR1900026002Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of xuefu zhuyu and clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Seattle Angina Inventory Scale, Angina symptom score and 2 more. Started Sep 2019; status: recruiting.
02
Drugs
xuefu zhuyuclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1900026002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026002.